Adicet Bio (ACET)
(Delayed Data from NSDQ)
$2.03 USD
-0.25 (-10.79%)
Updated Apr 18, 2024 04:00 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ACET 2.03 -0.25(-10.79%)
Will ACET be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for ACET based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ACET
Why Adicet Bio (ACET) Stock Might be a Great Pick
Evaxion (EVAX) Up on Upbeat Preclinical S. Aureus Vaccine Data
ACET: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Adicet Bio (ACET) Outperforming Other Medical Stocks This Year?
Apogee (APGE) Stock Rallies 95.6% in a Month: Here's Why
Akebia (AKBA) Up as Vafseo Gets FDA Nod for Anemia Due to CKD
Other News for ACET
Adicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual Conference
Analysts Offer Insights on Healthcare Companies: Genelux Corp. (GNLX), Adicet Bio (ACET) and Entera Bio (ENTX)
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
The Penny Stock A-List: 7 High-Profile Companies on the Verge of Greatness
Adicet Bio (ACET) Receives a New Rating from Truist Financial